SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 137 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $222,000 | -70.5% | 11,542 | -73.3% | 0.03% | -67.3% |
Q1 2022 | $753,000 | +41.3% | 43,300 | +80.7% | 0.10% | +16.1% |
Q4 2020 | $533,000 | -3.4% | 23,958 | -36.0% | 0.09% | -5.4% |
Q3 2020 | $552,000 | +173.3% | 37,420 | +62.4% | 0.09% | +283.3% |
Q4 2019 | $202,000 | -11.8% | 23,041 | -6.1% | 0.02% | -7.7% |
Q2 2019 | $229,000 | +186.2% | 24,550 | +60.2% | 0.03% | +225.0% |
Q1 2019 | $80,000 | -78.3% | 15,323 | -70.8% | 0.01% | -55.6% |
Q2 2018 | $368,000 | – | 52,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 1,932,800 | $33,592,000 | 10.90% |
Aisling Capital Management LP | 1,025,000 | $17,815,000 | 9.61% |
Frazier Life Sciences Management, L.P. | 3,195,403 | $55,536,000 | 4.73% |
Paradigm Biocapital Advisors LP | 701,356 | $12,190,000 | 3.22% |
SPHERA FUNDS MANAGEMENT LTD. | 1,277,413 | $22,201,000 | 3.14% |
Nantahala Capital Management | 2,692,303 | $46,792,000 | 2.07% |
Avidity Partners Management LP | 4,823,400 | $83,831,000 | 1.75% |
DAFNA Capital Management LLC | 371,987 | $6,465,000 | 1.68% |
ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,582,000 | 1.67% |
BVF INC/IL | 2,394,714 | $41,620,000 | 1.66% |